Price Move History
- Daily moves over 5%
- 72 254 sessions, March 30, 2021 to March 30, 2022
- Largest daily move
- +301.5% close of June 10, 2021
- 1-year change
- -90.6% closing prices, March 30, 2021 to March 30, 2022
- 1-month change
- -28.7% closing prices, February 28, 2022 to March 30, 2022
Company Description
ORPH (Nasdaq: ORPH) is classified in the biotechnology industry within the Healthcare sector.
ORPH declined 90.6% in the 12 months to March 30, 2022. The last closing price was $0.8700.
This page collects what Stock Titan holds for ORPH, including price data and latest news.
Stock Performance
ORPH (ORPH) closed at $0.8700 on March 30, 2022. In the 12 months to March 30, 2022, the price lost 90.6%.
ORPH Metrics & Rankings
Price returns through March 30, 2022. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
ORPH has 7 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval, clinical trial. View all ORPH news →
SEC Filings
ORPH Company Profile & Sector Positioning
ORPH (ORPH) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing ORPH often look at related companies in the same sector, including Vertex Pharmaceuticals Inc (VRTX), Regeneron Pharmaceuticals Inc (REGN), Moderna, Inc. (MRNA), argenx SE (ARGX), and BeOne Medicines Ltd. (ONC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ORPH's relative position within its industry.